The improvement of histological features of NASH by OCA may be related to the activation of FXR, which reduces hepatic lipogenesis by downregulating transcription factor SREBP1c and increasing Sirtuin 1 (SIRT1) [21, 22]. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatohepatitis.